DHR

Danaher Corporation New York Stock Exchange
$268.43
Open: $268 High: $270.63 Low: $265.13 Close: $268.43
Range: 2021-06-23 - 2021-06-24
Volume: 5,451,056
Market: Open
Powered by Finage Stock APIDelayed data
DHR
Danaher Corporation 2200 Pennsylvania Avenue, NW Washington DC, 20037-1701 http://www.danaher.com
Danaher Corp designs, manufactures and markets professional, medical, industrial and commercial products and services. It markets its products under the brand of Beckman Coulter, Aperio, Dexis, Chemtreat and others.
  • CEO: Thomas P. Joyce
  • Employees: 67,000
  • Sector: Healthcare
  • Industry: Medical Diagnostics & Research
DHR News
Latest news about the DHR
  • If You Invested $1000 in Danaher a Decade Ago, This is How Much It'd Be Worth Now

    Why investing for the long run, especially if you buy certain popular stocks, could reap huge rewards.

    View More →
  • Here's How Investors Can Find Strong Multi-Sector Conglomerates Stocks with the Zacks ESP Screener

    Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.

    View More →
  • Danaher Schedules Second Quarter 2021 Earnings Conference Call

    Danaher Corporation (NYSE: DHR) announced that it will webcast its quarterly earnings conference call for the second quarter 2021 on Thursday, July 22, 2021 beginning at 8:00 a.m. ET and lasting approximately 1 hour.

    View More →
  • Breakout Bonanza: 3 Health Stocks Top Buy Points; Another Inches Up

    Health care stocks Intuitive Surgical and Danaher broke out on Monday, as Globus Medical flirted with a buy point.

    View More →
  • Danaher's (DHR) Aldevron Buyout to Aid Genomic Medicine

    Danaher (DHR) to gain from the Aldevron acquisition as it will increase growth opportunities in the genomic medicine field. The acquired assets will be integrated with Danaher's Life Sciences segment.

    View More →
  • The Zacks Analyst Blog Highlights: Target, NVIDIA, The Sherwin-Williams Co, Danaher Corp and FedEx

    The Zacks Analyst Blog Highlights: Target, NVIDIA, The Sherwin-Williams Co, Danaher Corp and FedEx

    View More →
  • Danaher (DHR) Moves 5% Higher: Will This Strength Last?

    Danaher (DHR) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.

    View More →
  • Danaher Snaps up Aldevron for $9.6B; Shares Spike 5%

    Shares of Danaher Corporation (DHR) jumped 5% on June 17 to close at $257.08 after the company inked a deal to acquire privately-held Aldevron in an all-cash transaction for $9.6 billion. Danaher is a global science and technology company that designs, manufactures, and markets professional, medical, industrial, and commercial products and services. Founded in 1998, Aldevron, a manufacturer of high-quality plasmid DNA, mRNA, and proteins, serves biotechnology and pharmaceutical customers across

    View More →
  • Danaher to Pay $9.6 Billion to Buy Aldevron, a Supplier to Covid-19 Vaccine Maker

    Aldevron makes biological components for messenger RNA-based vaccines and other cutting-edge medicines, and has been a key partner of Moderna.

    View More →
  • SCIEX OS Introduces New Software With OneOmics Suite and Molecule Profiler App

    FRAMINGHAM, Mass., Jun 17, 2021--SCIEX OS introduces new software with OneOmics suite in SCIEX Cloud and Molecule Profiler app.

    View More →
  • SCIEX Presents New Accurate Mass Instrument, The ZenoTOF 7600 System

    FRAMINGHAM, Mass., Jun 17, 2021--SCIEX presents the ZenoTOF 7600 system, a new accurate mass LC-MS/MS instrument that features the proprietary Zeno trap and EAD fragmentation.

    View More →
  • UPDATE 1-Danaher to buy biotech company Aldevron for about $9.6 billion

    Medical equipment maker Danaher Corp said on Thursday it would buy privately held biotech company Aldevron in an all-cash deal for about $9.6 billion. Danaher said it expects to finance the deal using cash on hand and/or proceeds from the issuance of commercial paper. Aldevron produces plasmid DNA, mRNA and proteins to help biotechnology and pharmaceutical customers across research, clinical and commercial fields.

    View More →
  • Danaher To Acquire Aldevron

    Danaher Corporation (NYSE: DHR) (the "Company") announced today that Danaher has entered into a definitive agreement to acquire privately-held Aldevron, for a cash purchase price of approximately $9.6 billion. Danaher expects to finance the acquisition using cash on hand and/or proceeds from the issuance of commercial paper.

    View More →
  • Time to Focus on Danaher (DHR) for Strong Earnings Growth Potential

    If you are looking for a fast-growing stock that is still seeing plenty of opportunities on the horizon, make sure to consider Danaher (DHR).

    View More →
  • Danaher Gains On $9.6 Billion Aldevron Buy For Genomic Play

    By Dhirendra Tripathi

    View More →
  • 5 Picks as Inflation is Transitory and Tapering Is Not in View

    We have narrowed down our search to five corporate bigwigs that have provided better returns than the S&P 500 Index in the past three months. These are: FDX, SHW, DHR, TGt and NVDA.

    View More →
  • Danaher to Purchase Biotech Aldevron in $9.6 Billion Deal

    Danaher shares on Thursday were higher after the medical products and services provider said it had agreed to buy privately held biotech Aldevron for about $9.6 billion cash. Danaher said it expected to finance the acquisition using cash on hand or by issuing commercial paper. Aldevron, Fargo, N.D., will join Danaher's life sciences segment.

    View More →
  • Here's Why it is Worth Investing in Griffon (GFF) Stock Now

    Griffon (GFF) is likely to benefit from favorable macro trends, solid product offerings, well diversified business structure, sound manufacturing capacity, buyouts & shareholder-friendly policies.

    View More →
  • Zacks.com featured highlights include: 1-800-FLOWERS.COM, Polaris, The Sherwin-Williams Co, Danaher Corp and Navient Corp

    Zacks.com featured highlights include: 1-800-FLOWERS.COM, Polaris, The Sherwin-Williams Co, Danaher Corp and Navient Corp

    View More →
  • 5 of the Best Stocks to Invest in for Superb Earnings Growth

    1800 FLOWERS.COM (FLWS), Polaris (PII) & Danaher (DHR) are some of the top stocks that have striking earnings growth and positive estimate revisions at present.

    View More →